Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors

NCT02065063

Conditions: Cancer, Melanoma, Neoplasms, +10 more
Locations: GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Nashville, Tennessee, United States

GSK Investigational Site Houston, Texas, United States

View Trial Details

Completed

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

NCT03541148

Conditions: Cutaneous Melanoma, Stage II, Cutaneous Melanoma, Stage III, Malignant Cutaneous Melanoma, +13 more
Locations: Manuel Fajardo Clinical Surgical University Hospital La Habana, Cuba

View Trial Details

Completed

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00450255

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +22 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

The Jules Bordet Institute Molecular Profiling Program Feasibility Trial

NCT01932489

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
Locations: Jules Bordet Institute Brussels, Belgium

View Trial Details

Completed

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity

NCT01323517

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma

NCT02138292

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

NCT00256282

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Chao Family Comprehensive Cancer Center Orange, California, United States

View Trial Details

Completed

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

NCT00938223

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

NCT00626405

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Providence Cancer Center Anchorage, Alaska, United States

Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

View all 259 locations

View Trial Details

Completed

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

NCT03504696

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Nantes, France

View Trial Details

Melanoma

Melanoma trial results

Related conditions